.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Moodys
Johnson and Johnson
Citi
US Department of Justice
US Army
Fuji
Mallinckrodt
Boehringer Ingelheim
Julphar

Generated: July 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 085870

« Back to Dashboard
NDA 085870 describes POTASSIUM CHLORIDE, which is a drug marketed by Lupin Ltd, Baxter Hlthcare, Abraxis Pharm, Actavis Labs Fl Inc, Hospira, Watson Labs, Kremers Urban Pharms, Lehigh Valley, Fresenius Kabi Usa, Copley Pharm, Pharma Res Software, Gd Searle Llc, Luitpold, Amneal Pharms, Novel Labs Inc, Sigmapharm Labs Llc, Teva, Schering, Tris Pharma Inc, Nesher Pharms, PII, Pharma Serve Ny, Glenmark Pharms Ltd, Mylan Pharms Inc, Intl Medication, Adare Pharms Inc, Lilly, B Braun, Paddock Llc, Anchen Pharms, Akorn, Miles, and Icu Medical Inc, and is included in seventy-six NDAs. It is available from forty-eight suppliers. Additional details are available on the POTASSIUM CHLORIDE profile page.

The generic ingredient in POTASSIUM CHLORIDE is calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate. There are two hundred and sixty-eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate profile page.

Summary for NDA: 085870

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 085870

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
POTASSIUM CHLORIDE
potassium chloride
INJECTABLE;INJECTION 085870 ANDA B. Braun Medical Inc. 0264-1940 0264-1940-20 12 CONTAINER in 1 CASE (0264-1940-20) > 250 mL in 1 CONTAINER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2MEQ/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Express Scripts
Chubb
AstraZeneca
Cipla
McKinsey
Moodys
Argus Health
UBS
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot